Literature DB >> 1615215

LH-RH antagonists: state of the art and future perspectives.

G F Weinbauer1, E Nieschlag.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1615215     DOI： 10.1007/978-88-470-2186-0_11

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN： 0080-0015


× No keyword cloud information.
  8 in total

Review 1.  The future of antihormone therapy: innovations based on an established principle.

Authors:  K Parczyk; M R Schneider
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

2.  Effect of the concurrent LHRH antagonist administration with a LHRH superagonist in rats.

Authors:  J W Kostanski; B A Dani; B Schrier; P P DeLuca
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

3.  Gonadotropin-releasing hormone analogue conjugates with strong selective antitumor activity.

Authors:  I Pályi; B Vincze; S Lovas; I Mezö; J Pató; A Kálnay; G Turi; D Gaál; R Mihalik; I Péter; I Teplán; R F Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

4.  Influence on antiproliferative activity of structural modification and conjugation of gonadotropin-releasing hormone (GnRH) analogues.

Authors:  A Kálnay; I Pályi; B Vincze; R Mihalik; I Mezõ; J Pató; J Seprõdi; S Lovas; R F Murphy
Journal:  Cell Prolif       Date:  2000-10       Impact factor: 6.831

5.  Population pharmacokinetic/pharmacodynamic (PK/PD) modelling of the hypothalamic-pituitary-gonadal axis following treatment with GnRH analogues.

Authors:  Christoffer W Tornøe; Henrik Agersø; Thomas Senderovitz; Henrik A Nielsen; Henrik Madsen; Mats O Karlsson; E Niclas Jonsson
Journal:  Br J Clin Pharmacol       Date:  2006-11-10       Impact factor: 4.335

6.  Evaluation of Orntide microspheres in a rat animal model and correlation to in vitro release profiles.

Authors:  J W Kostanski; B A Dani; G A Reynolds; C Y Bowers; P P DeLuca
Journal:  AAPS PharmSciTech       Date:  2000-10-01       Impact factor: 3.246

7.  Population pharmacokinetic modeling of a subcutaneous depot for GnRH antagonist degarelix.

Authors:  Christoffer W Tornøe; Henrik Agersø; Henrik A Nielsen; Henrik Madsen; E Niclas Jonsson
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

8.  Return to fertility after extended chemical castration with a GnRH antagonist.

Authors:  J W Kostanski; G Jiang; B A Dani; S B Murty; W Qiu; B Schrier; B C Thanoo; P P DeLuca
Journal:  BMC Cancer       Date:  2001-10-29       Impact factor: 4.430
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.